Is Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum? Is Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum safe for nursing mother and child? Does Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum extracts into breast milk? Does Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum has any long term or short term side effects on infants? Can Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum influence milk supply or can Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum decrease milk supply in lactating mothers?
Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum lactation summary
- DrLact safety Score for Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum usage in lactation
It is a glycoside-sulphate derivative (sucrose) plus aluminum.
At latest update no published data on excretion into breastmilk were found.
Pharmacokinetic data (virtually non-absorbed with a high molecular weight) make it very unlikely the excretion into breastmilk in significant amounts, which in addition it would not be absorbed through the infant's intestine.
Medication with authorized use on infants.
Answer by DrLact: About Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum usage in lactation
No data are available on Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum use during breastfeeding; however, it is virtually unabsorbed orally. Most authorities consider Hexadeca-U-hydroxytetracosahydroxy-(U8-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-))) hexadecaaluminum acceptable to use during breastfeeding.[1][2][3][4] No special precautions are required.
Alternate Drugs
Lansoprazole(Safe)
Dexlansoprazole(Safe)
Esomeprazole(Safe)
Misoprostol(Safe)
Ranitidine(Safe)
Omeprazole(Safe)
Nizatidine(Safe)
Sucralfate(Safe)
Famotidine(Safe)
Rabeprazole(Safe)
Cimetidine(Low Risk)
Pantoprazole(Safe)
Magnesium Oxide(Safe)
Docusate(Safe)
Dimenhydrinate(Low Risk)
Esomeprazole(Safe)
Cisapride(Safe)
Sodium Picosulfate(Safe)
Cascara Sagrada(Low Risk)
Ranitidine(Safe)
Misoprostol(Safe)
Rifaximin(Safe)
Bisacodyl(Safe)
Adalimumab(Safe)
Omeprazole(Safe)
Domperidone(Safe)
Peppermint(Safe)
Sulfasalazine(Safe)
Ursodiol(Safe)
Nizatidine(Safe)
Cyclizine(Low Risk)
Olsalazine(Safe)
Sucralfate(Safe)
Mesalamine(Safe)
Alosetron(Low Risk)
Famotidine(Safe)
Octreotide(Safe)
Loperamide(Safe)
Trimethobenzamide(Unsafe)
Senna(Safe)
Rabeprazole(Safe)
Cimetidine(Low Risk)
Metoclopramide(Safe)
Pantoprazole(Safe)
Linaclotide(Safe)
Magnesium Sulfate(Safe)
Thiethylperazine(Unsafe)
Certolizumab Pegol(Safe)
Magnesium Hydroxide(Safe)
Prochlorperazine(Unsafe)
Droperidol(Low Risk)
Lansoprazole(Safe)
Doxylamine(Unsafe)
Infliximab(Safe)
Etanercept(Safe)
Dexlansoprazole(Safe)